Harvard's Office of Technology Development and LabCentral co-host the Guppy Tank series, where Harvard life-science innovators pitch their early-stage concepts to a panel of entrepreneurs and investors for constructive, in-depth feedback.
Guppy Tank events provide industry exposure and input to research teams early in the business development process to enable them to move forward in a productive direction with their projects and position it for success. The event acts as a training tool for research teams to pitch their technology and engage in a valuable discussion with investors, entrepreneurs, and fellow scientists.
The Guppy Tank series has been running for 8 years with 30+ presentations and networking sessions.
November 4th, 2026
LabCentral, 700 Main Street Cambridge, MA 02139 Map
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
September 26th, 2024
LabCentral, 700 Main Street Cambridge, MA 02139 Map
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
May 7th, 2024
LabCentral, 700 Main Street Cambridge, MA 02139 Map
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
March 7th, 2024
Northwest Building, Room B103
52 Oxford Street Cambridge, MA 02138
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
November 15th, 2023
LabCentral, 700 Main Street Cambridge, MA 02139 MAP
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
This event features a technology from the Church Lab presented by Dr. Erik Aznauryan, Post-Doctoral Research Fellow, Harvard Medical School, and Wyss Technology Development Fellow.
June 27th, 2023
Lab Central, 700 Main Street, North Cambridge, MA 02139 MAP
Harvard life-science innovators pitch their concepts to a panel of entrepreneurs and investors for constructive feedback.
This event features a technology from the Silver Lab presented by Jeffrey Way Ph.D., President of General Biologics. General Biologics is developing a product for treatment of hypoxia, which could be used to treat chronic obstructive pulmonary disease (16 million patients in the US alone), cystic fibrosis, and patients on ventilators.
